A Phase III, Double-Blind, Randomized Study to Evaluate

Project: Research project

Project Details

Description

A Phase III, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
StatusFinished
Effective start/end date7/20/1112/31/14

Funding

  • Astellas Pharma US, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.